17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Novel, Gel-free Proteomics Approach Identifies RNF5 and JAMP as Modulators of GPCR Stability

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The maturation and folding of G protein-coupled receptors are governed by mechanisms that remain poorly understood. In an effort to characterize these biological events, we optimized a novel, gel-free proteomic approach to identify partners of the β 2-adrenergic receptor (β 2AR). In addition to a number of known interacting proteins such as heterotrimeric G protein subunits, this allowed us to identify proteins involved in endoplasmic reticulum (ER) QC of the receptor. Among β 2AR-associated proteins is Ring finger protein 5 (RNF5), an E3 ubiquitin ligase anchored to the outer membrane of the ER. Coimmunoprecipitation assays confirmed, in a cellular context, the interaction between RNF5 and the β 2AR as well as the prostaglandin D 2 receptor (DP). Confocal microscopy revealed that DP colocalized with RNF5 at the ER. Coexpression of RNF5 with either receptor increased levels of their expression, whereas small interfering RNA-mediated knockdown of endogenous RNF5 promoted the opposite. RNF5 did not modulate the ubiquitination state of β 2AR or DP. Instead, RNF5 ubiquitinated JNK-associated membrane protein (JAMP), a protein that recruits the proteasome to the ER membrane and that is negatively regulated by RNF5-mediated ubiquitination. JAMP coimmunoprecipitated with both β 2AR and DP and decreased total receptor protein levels through proteasomal degradation. Expression of DP, a receptor largely retained in the ER, promoted proteasome recruitment by JAMP. Degradation of both receptors via JAMP was increased when RNF5 was depleted. Our data suggest that RNF5 regulates the turnover of specific G protein-coupled receptors by ubiquitinating JAMP and preventing proteasome recruitment.

          Related collections

          Author and article information

          Journal
          Mol Endocrinol
          Mol. Endocrinol
          mend
          mend
          Molecular Endocrinology
          Endocrine Society (Chevy Chase, MD )
          0888-8809
          1944-9917
          August 2013
          24 June 2013
          : 27
          : 8
          : 1245-1266
          Affiliations
          Service de Rhumatologie (S.J.R., L.F., C.I.-M., C.B., J.-L.P.), Département de Médecine, Université de Sherbrooke, the Institut de Pharmacologie de Sherbrooke, and the Centre de Recherche Clinique Etienne-Lebel, Sherbrooke, Québec, J1H 5N4 Canada; Department of Pharmacology and Therapeutics (I.G., D.P., P.T., T.E.H.), McGill University, Montréal, Québec, H3G 1Y6 Canada; and Department of Pharmaceutical Sciences (M.R., S.A.), Leslie Dan Faculty of Pharmacy, Faculty of Medicine, University of Toronto, Toronto, Ontario, M5S 3M2 Canada
          Author notes
          Address all correspondence and requests for reprints to: Terence E. Hébert, Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Room 1303, Montréal, Québec, H3G 1Y6, Canada. E-mail: terence.hebert@ 123456mcgill.ca ; or Jean-Luc Parent, Service de Rhumatologie, Université de Sherbrooke, 3001 12 e Avenue, Nord, Sherbrooke, Québec, J1H 5N4, Canada. E-mail: jean-luc.parent@ 123456usherbrooke.ca .
          [*]

          S.J.R. and I.G. contributed equally to this work.

          [†]

          T.E.H. and J.-L.P. are co-corresponding authors.

          Article
          PMC5427950 PMC5427950 5427950 ME-13-1091
          10.1210/me.2013-1091
          5427950
          23798571
          afec4ebf-58d4-4619-adb7-25a8c8d7f1a1
          Copyright © 2013 by The Endocrine Society
          History
          : 3 April 2013
          : 13 June 2013
          Funding
          Funded by: Canadian Institutes of Health Research
          Funded by: Chercheur boursier-Sénior salary award from the Fonds de la Recherche en Santé du Québec (FRSQ)
          Funded by: André-Lussier Research Chair
          Funded by: FRSQ
          Funded by: Chercheur National of the FRSQ
          Funded by: McGill CIHR Drug Development Training Program
          This work was supported by grants from the Canadian Institutes of Health Research to T.E.H., J.-L.P., and S.A. J.-L. P. was the recipient of a Chercheur boursier-Sénior salary award from the Fonds de la Recherche en Santé du Québec (FRSQ) and holder of the André-Lussier Research Chair during this work. C.I.M. received a MD-PhD scholarship from the FRSQ. T.E.H. is a Chercheur National of the FRSQ. I.G. received a scholarship from the McGill CIHR Drug Development Training Program.
          Categories
          Original Research

          Comments

          Comment on this article